Early intensive insulin therapy in patients with type 2 diabetes

wang zimu,chen xiaotong,chen huimei
DOI: https://doi.org/10.11724/jdmu.2017.05.20
2017-01-01
Abstract:Type 2 diabetes is a metabolic disease characterized by the progressive deterioration of islet B cell function and insulin resistance. Early intensive insulin therapy,as a novel strategy of type 2 diabetes,can improve islet B cell function and insulin resistance by achieving restrictive glycemic control using insulin. This therapy enables patients to maintain normal blood glucose level after the therapy merely on lifestyle interventions and diet control. However,early intensive insulin therapy may cause some side effects,including increased risk of hypoglycemia and weight gain. This article reviews the definition,the therapeutic schemes,the effects and possible problems of early intensive insulin therapy. We hope that we can help physicians and medical students learn more about this therapy.
What problem does this paper attempt to address?